imipramine has been researched along with Myelopathy in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stockamp, K | 1 |
| Herrmann, H | 1 |
| Schreiter, F | 1 |
| Chase, TN | 1 |
1 review available for imipramine and Myelopathy
| Article | Year |
|---|---|
Serotonergic mechanisms and extrapyramidal function in man.
Topics: 5-Hydroxytryptophan; Carbidopa; Cerebellar Diseases; Creutzfeldt-Jakob Syndrome; Down Syndrome; Extr | 1974 |
1 other study available for imipramine and Myelopathy
| Article | Year |
|---|---|
Conservative bladder treatment in myelodysplasia. Differentiation of patients by cystomanometry.
Topics: Adolescent; Child; Child, Preschool; Colon; Diazepam; Dilatation, Pathologic; Female; Humans; Imipra | 1976 |